|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
6
|
|
pubmed:dateCreated |
2009-6-11
|
|
pubmed:abstractText |
Hepatoprotective therapies that include regular glycyrrhizin injections (GIs) are beneficial for chronic hepatitis C patients, but are sometimes insufficient for normalizing serum alanine aminotransferase (ALT) levels. Here, we evaluated whether the addition of minor bloodletting, named petit phlebotomy (PP), prior to each GI could further reduce serum ALT concentrations in such patients.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:issn |
0944-1174
|
|
pubmed:author |
pubmed-author:AoyamaToshifumiT,
pubmed-author:HoriuchiAkiraA,
pubmed-author:KiyosawaKendoK,
pubmed-author:KomatsuMichiharuM,
pubmed-author:NagayaTadanobuT,
pubmed-author:OkaniwaShinjiS,
pubmed-author:TanakaEijiE,
pubmed-author:TanakaNaokiN,
pubmed-author:YamauraTakahiroT,
pubmed-author:YokoyamaTakahideT,
pubmed-author:YoshizawaKanameK
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
44
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
577-82
|
|
pubmed:meshHeading |
pubmed-meshheading:19352587-Aged,
pubmed-meshheading:19352587-Alanine Transaminase,
pubmed-meshheading:19352587-Anti-Inflammatory Agents,
pubmed-meshheading:19352587-Bloodletting,
pubmed-meshheading:19352587-Combined Modality Therapy,
pubmed-meshheading:19352587-Female,
pubmed-meshheading:19352587-Ferritins,
pubmed-meshheading:19352587-Glycyrrhizic Acid,
pubmed-meshheading:19352587-Hepatitis C, Chronic,
pubmed-meshheading:19352587-Humans,
pubmed-meshheading:19352587-Male,
pubmed-meshheading:19352587-Middle Aged,
pubmed-meshheading:19352587-Prospective Studies,
pubmed-meshheading:19352587-Treatment Outcome
|
|
pubmed:year |
2009
|
|
pubmed:articleTitle |
Efficacy and safety of addition of minor bloodletting (petit phlebotomy) in hepatitis C virus-infected patients receiving regular glycyrrhizin injections.
|
|
pubmed:affiliation |
Department of Metabolic Regulation, Shinshu University Graduate School of Medicine, Asahi 3-1-1, Matsumoto 390-8621, Japan. naopi@shinshu-u.ac.jp
|
|
pubmed:publicationType |
Journal Article,
Randomized Controlled Trial
|
